Study Guide to Psychopharmacology is a question-and-answer companion that allows you to evaluate your mastery of the subject matter as you progress through The American Psychiatric Publishing Textbook of Psychopharmacology, Fourth Edition. The Study Guide is made up of 368 questions divided into 67 individual quizzes of 5–10 questions each that correspond to chapters in the Textbook. Questions are followed by an Answer Guide that references relevant text (including the page number) in the Textbook to allow quick access to needed information. Each answer is accompanied by a discussion that not only addresses the correct response but also explains why other responses are not correct.
The Study Guide's companion, The American Psychiatric Publishing Textbook of Psychopharmacology, has been updated to keep you current with the latest research and trends in the field. Covering both basic science and clinical practice, this new edition draws on the talents of 53 new contributors to guarantee fresh, authoritative perspectives on advances in psychiatric drug therapy.
Part I: Principles of Psychopharmacology. Neurotransmitters, receptors, signal transduction, and second messengers in psychiatric disorders. Chapter two: basic principles of molecular neurobiology. Genomics and genetics. Chemical neuroanatomy of the mammalian primate brain. Electrophysiology. Animal models. Psychoneuroendocrinology. Principles of pharmacokinetics and pharmacodynamics. Brain–immune system interactions: relevance to the pathophysiology and treatment of neuropsychiatric disorders. Brain imaging in psychopharmacology. Statistics, placebo response, and clinical trial design in psychopharmacology. Part II. Classes of Psychiatric Treatments: Animal and Human Pharmacology. Tricyclic and tetracyclic drugs. Fluoxetine. Sertraline. Paroxetine. Fluvoxamine. Citalopram and s-citalopram. Monoamine oxidase inhibitors. Trazodone and nefazodone. Bupropion. Mirtazapine. Venlafaxine and desvenlafaxine. Duloxetine and milnacipran. Benzodiazepines. Buspirone and gepirone. Investigational treatments for mood and anxiety disorders: CRH receptor antagonists, NK-1 receptor antagonists, glucocorticoid receptor antagonists, and agomelatine. Classic antipsychotic medications. Clozapine. Olanzapine. Quetiapine. Aripiprazole. Ziprasidone. Drugs to Treat Extrapyramidal Side Effects. Lithium – drugs to treat bipolar disorder. `valproate. Carbamazepine and oxcarbazepine. Gabapentin and pregabablin. Lamotrigine. Topiramate. Cognitive enhancers. Sedative-hypnotics. Psychostimulants in psychiatry: amphetamine, methylphenidate, and modafinil. Electroconvulsive therapy. Part III: Clinical Psychobiology and Psychiatric Syndromes. Biology of Mood Disorders. Neurobiology of schizophrenia. Neurobiology of anxiety disorders. Biology of alzheimer’s disease. Neurobiology of substance abuse disorders. Biology of eating disorders. Biology of personality disorder. Biology of childhood disorders. Part IV. Psychopharmacological Treatment. Treatment of depression. Treatment of bipolar disorder. Treatment of schizophrenia. Treatment of anxiety disorders. Treatment of agitation and aggression in the elderly. Treatment of substance-related disorders. Treatment of eating disorders. Treatment of insomnia. Treatment of personality disorders. Psychiatric emergencies. Treatment of childhood and adolescent disorders. Psychopharmacology during pregnancy and lactation. Treatment during late life. Treatment of chronic pain syndromes. Ethical issues in psychopharmacology. Index.
About the Authors:
Robert E. Hales, M.D., M.B.A., is the Joe P. Tupin Professor and Chair of the Department of Psychiatry at the University of California, Davis School of Medicine. He is also the Editor-in-Chief of the American Psychiatric Publishing, Inc., and Medical Director of the Sacramento County Mental Health Service in Sacramento, California.
Narriman C. Shahrokh is Chief Administrative Officer in the Department of Psychiatry and Behavioral Sciences at the University of California, Davis, School of Medicine in Sacramento, California.
Alan F. Schatzberg, M.D., is Kenneth T. Norris Jr. Professor and Chair of the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine in Stanford, California.
Charles B. Nemeroff, M.D., Ph.D., is Reunette W. Harris Professor in the Department of Psychiatry and Behavioral Sciences at Emory University School of Medicine in Atlanta, Georgia.